Impact of an Optimized Communication on the Readmission for Adverse Drug Event
Condition(s):Adverse Drug EventLast Updated:May 5, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Adverse Drug EventLast Updated:May 5, 2022Completed
Condition(s):Adverse Drug Event; Readmission; Patient ComplianceLast Updated:February 23, 2016Completed
Condition(s):Personal SatisfactionLast Updated:April 19, 2017Completed
Condition(s):Hip Fractures; Aging; Patient FallLast Updated:June 29, 2023Completed
Condition(s):Drug Related Problems Post Hospital Discharge; Healthcare Utilization; Discharge Medication CounselingLast Updated:November 13, 2014Completed
Condition(s):Drug-Related ProblemsLast Updated:April 12, 2021Unknown status
Condition(s):Drug-Related Side Effects and Adverse Reactions; Adverse Drug EventsLast Updated:November 19, 2020Completed
Condition(s):Pneumonia; COPD Asthma; COPD ExacerbationLast Updated:October 5, 2022Completed
Condition(s):Medication Compliance; Drug-Related Side Effects and Adverse Reactions; Remission; Medicinal Substance; Adverse Effect; Drug Interaction PotentiationLast Updated:February 21, 2023Completed
Condition(s):Incidence of Readmissions; ADE’s Due to AnticoagulantsLast Updated:February 28, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.